T1	Participants 364 418	patients with laryngeal squamous cell carcinoma (LSCC)
T2	Participants 581 643	Skp2 overexpression was observed in 36.7% (37 of 102) patients
T3	Participants 1032 1104	patients with both Skp2 overexpression and reduced expression of p27kip1
